NeuroHagana

NeuroHagana Overview

NeuroHagana (NH) develops an injectable emergency treatment for neurotrauma, irrespective of its type or severity. The novel treatment acts immediately to protect against the main factor in Neurotrauma pathology: Glutamate Excitotoxicity. NH’s technology has been pre-clinically validated in animal models of Spinal Cord Injury, Traumatic Brain Injury, and Athletes Concussion, with no side effects. The new treatment reduces the toxic impact of excessive Glutamate levels in the Central Nervous System, preventing irreversible neuronal damage and physical disabilities. First applications will be Spinal Cord Injury, first in Europe and USA. Other applications will be Traumatic Brain Injury and Stroke. Essential for paramedics, hospital trauma units, first aid teams and military forces, the new innovative drug aims to become a vital component of any core emergency kit, preventing permanent disabilities of the injured people and giving them the opportunity to regain their freedom.

Latest News

May 28, 2025 · praxisinstitute.org

growth-positive

SCI Incubate 2025 Cohort - Praxis Spinal Cord Institute

Praxis Spinal Cord Institute has launched the Praxis SCI Incubate program, a four-month initiative aimed at supporting prototype stage projects that innovate in the field of spinal cord injury (SCI) treatment. The program includes mentorship, research validation, and access to a commercialization network. Participating startups include DeCell Technologies, GraspAgain, NeuroHagana, and Tarkka, each working on groundbreaking solutions to improve the quality of life for individuals with SCI. These startups will benefit from mentorship and networking opportunities to enhance their growth. DeCell Technologies is developing DermGEN™, a biomaterial for wound treatment, while NeuroHagana focuses on neuroprotective treatments. GraspAgain is creating an AI-driven neuroorthosis for hand function restoration, and Tarkka is innovating in wheelchair seating solutions.

Product Stage

Funding

Team Members

3

Employees: 1-10

Web & Social Links

Locations

Tel Aviv-Yafo, Israel

Photos & Videos

2 item(s)

NeuroHagana Internal

Recent Updates

No update log entries.

Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.

Admin Info